Pharmacoeconomic Analysis of Adjuvant Therapy with Exemestane, Anastrozole, Letrozole or Tamoxifen in Postmenopausal Women with Operable and Estrogen Receptor-Positive Breast Cancer
Clinical & translational oncology（2006）
Abstract
To compare the efficiency of adjuvant therapy with aromatase inhibitors or with tamoxifen in postmenopausal women with operable breast cancer and positive estrogen receptors.
MoreTranslated text
Key words
exemestane,tamoxifen,anastrozole,letrozole,breast cancer,cost-utility,cost-effectiveness,life-year gained (LYG),quality adjusted life year (QALY)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined